CVE-2019-1662

Cisco Prime Collaboration Assurance Software Unauthenticated Access Vulnerability

Description

A vulnerability in the Quality of Voice Reporting (QOVR) service of Cisco Prime Collaboration Assurance (PCA) Software could allow an unauthenticated, remote attacker to access the system as a valid user. The vulnerability is due to insufficient authentication controls. An attacker could exploit this vulnerability by connecting to the QOVR service with a valid username. A successful exploit could allow the attacker to perform actions with the privileges of the user that is used for access. This vulnerability affects Cisco PCA Software Releases prior to 12.1 SP2.

Category

8.2
CVSS
Severity: High
CVSS 3.0 •
CVSS 2.0 •
EPSS 1.43% Top 25%
Vendor Advisory cisco.com
Affected: Cisco Cisco Prime Collaboration Assurance
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2019-1662?
CVE-2019-1662 has been scored as a high severity vulnerability.
How to fix CVE-2019-1662?
To fix CVE-2019-1662, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2019-1662 being actively exploited in the wild?
It is possible that CVE-2019-1662 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2019-1662?
CVE-2019-1662 affects Cisco Cisco Prime Collaboration Assurance.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.